Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Sanofi    crawled date : 2021 - 03 - 23    save search

Asher Raises $55 Million Series A for Targeted Cancer Immunotherapies
Published: 2021-03-23 (Crawled : 19:00) - biospace.com/
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%

cancer immunotherapy
Paroxysmal Nocturnal Hemoglobinuria Market Landscape Set to Witness Growth at a CAGR of 10% for the Study Period 2018-30 in the 7MM | DelveInsight
Published: 2021-03-23 (Crawled : 18:00) - prnewswire.com
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%

growth
Alphamab Oncology Reports Full Year 2020 Financial Results and Business Highlights
Published: 2021-03-23 (Crawled : 15:15) - prnewswire.com
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%

financial results results
Four More Biopharma Companies Set Sights on IPOs
Published: 2021-03-23 (Crawled : 15:00) - biospace.com/
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%

biopharma set
Herborium Moves to the Next Level in Building a Disruptive, Integrated, Natural Medicine Content and Commerce Platform
Published: 2021-03-23 (Crawled : 15:00) - globenewswire.com
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%


Two Cell Therapy Companies Bag New CEOs
Published: 2021-03-23 (Crawled : 14:00) - biospace.com/
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%

therapy new ceo ceo leo
Pharma Industry to Spend $4.5 Billion on Digital Transformation by 2030
Published: 2021-03-23 (Crawled : 09:00) - prnewswire.com
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%

pharma
Phase 3 Trial Shows REGEN-COV™ (casirivimab with imdevimab) Antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients
Published: 2021-03-23 (Crawled : 07:00) - prnewswire.com
SNY | News | $46.82 -1.82% 510K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.22% C: -1.32%
REGN | News | $911.73 0.49% 97K twitter stocktwits trandingview |
Health Technology
| | O: 0.61% H: 0.53% C: -3.37%

covid antibody phase 3 trial casirivimab
Gainers vs Losers
54% 46%

Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.04 121.24% 9.6M twitter stocktwits trandingview |

BOF | $2.05 75.21% 78M twitter stocktwits trandingview |

AMST | $3.2 60.0% 63M twitter stocktwits trandingview |
Technology Services

LICN | $0.8592 53.43% 13M twitter stocktwits trandingview |

WIMI | $1.05 44.75% 13M twitter stocktwits trandingview |
Technology Services

TROO | $1.51 38.53% 5.6M twitter stocktwits trandingview |
Manufacturing

MULN | News | $3.675 34.62% 11M twitter stocktwits trandingview |
Information

RILY | $27.91 28.5% 8.9M twitter stocktwits trandingview |
Finance

WHLM | $6.43 26.58% 580K twitter stocktwits trandingview |
Commercial Services


Your saved searches
Save your searches and get alerts when important news are released.